Roche moved to enter the booming weight-loss drug market now dominated by Novo Nordisk and Eli Lilly. The Swiss ...
(RTTNews) - Zealand Pharma ... Roche (RHHBY) to develop petrelintide, Zealand Pharma's amylin analog. The two companies will co-develop and co-commercialize petrelintide and combination products ...